GlassScriptPhysician profile
Irene A Malek
NPI 1316984248
$1,980.81
in general payments reported to CMS, 2019-2025
17 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $85.14 · 2021: $25.48 · 2022: $101 · 2023: $353 · 2024: $550 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.75 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $569.89 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $304.59 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $205.96 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $172.75 | 2019-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.13 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $148.10 | 2022-2025 | Freestyle Libre 3, Id Now Instrument |
| Pfizer INC. | $100.73 | 2019-2024 | |
| Amarin Pharma, INC. | $53.84 | 2019 | |
| Amgen INC. | $50.81 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.57 | 2024 | Jardiance |
| Abbvie INC. | $30.46 | 2024 | |
| Phathom Pharmaceuticals, INC. | $26.82 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $25.63 | 2025 | |
| Ethicon US, LLC | $25.53 | 2025 | Harmonic |
| Dexcom, INC. | $22.67 | 2024 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.60 | 2024 | Veozah |
| Nevro Corp. | $12.73 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Malek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.